Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EST / 2:00 p.m. GMT on Thursday, ...
The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...
1d
Condé Nast Traveler on MSNWhat You Need to Know About the Risk of Blood Clots on Long FlightsOne study found that most people are at risk for developing DVT on one out of every 4,656 long flights, which is a relatively ...
In addition to cigarette smoke, other chemicals may also raise a nonsmoking woman's risk of developing lung cancer. These compounds may be present in your home or place of employment. Among the ...
Discover eight promising respiratory disease companies advancing their novel therapies through clinical trials in 2025.
Discover protective tips to lower lung cancer risk even with a smoking history. Proven approaches for current and former ...
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...
Delhi NCR is witnessing a sharp rise in cases of influenza, including swine flu, with many residents experiencing prolonged ...
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing ... committee, which found that GSK had not proved ...
4don MSN
The hospital is the only state facility listed among top performers in the U.S. on Healthgrades national rankings.
Feb. 14, 2025 — A study has found microscopic particles emitted ... New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce ...
Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results